Global Needle-Free Drug Delivery Systems Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Needle-Free Drug Delivery Systems market report explains the definition, types, applications, major countries, and major players of the Needle-Free Drug Delivery Systems market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Antares Pharma

    • Crossject

    • MedImmune

    • Injex Pharma

    • Optinose

    • Pharmajet

    • Zogenix

    • Valeritas

    • 3M Pharmaceuticals

    • Becton Dickinson (BD)

    • Mystic Pharmaceuticals

    By Type:

    • Jet-based

    • Spring-based

    • Laser-based

    By End-User:

    • Hospital

    • Clinic

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Needle-Free Drug Delivery Systems Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Needle-Free Drug Delivery Systems Outlook to 2028- Original Forecasts

    • 2.2 Needle-Free Drug Delivery Systems Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Needle-Free Drug Delivery Systems Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Needle-Free Drug Delivery Systems Market- Recent Developments

    • 6.1 Needle-Free Drug Delivery Systems Market News and Developments

    • 6.2 Needle-Free Drug Delivery Systems Market Deals Landscape

    7 Needle-Free Drug Delivery Systems Raw Materials and Cost Structure Analysis

    • 7.1 Needle-Free Drug Delivery Systems Key Raw Materials

    • 7.2 Needle-Free Drug Delivery Systems Price Trend of Key Raw Materials

    • 7.3 Needle-Free Drug Delivery Systems Key Suppliers of Raw Materials

    • 7.4 Needle-Free Drug Delivery Systems Market Concentration Rate of Raw Materials

    • 7.5 Needle-Free Drug Delivery Systems Cost Structure Analysis

      • 7.5.1 Needle-Free Drug Delivery Systems Raw Materials Analysis

      • 7.5.2 Needle-Free Drug Delivery Systems Labor Cost Analysis

      • 7.5.3 Needle-Free Drug Delivery Systems Manufacturing Expenses Analysis

    8 Global Needle-Free Drug Delivery Systems Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Needle-Free Drug Delivery Systems Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Needle-Free Drug Delivery Systems Export by Region (Top 10 Countries) (2017-2028)

    9 Global Needle-Free Drug Delivery Systems Market Outlook by Types and Applications to 2022

    • 9.1 Global Needle-Free Drug Delivery Systems Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Jet-based Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Spring-based Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Laser-based Consumption and Growth Rate (2017-2022)

    • 9.2 Global Needle-Free Drug Delivery Systems Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Needle-Free Drug Delivery Systems Market Analysis and Outlook till 2022

    • 10.1 Global Needle-Free Drug Delivery Systems Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.2.2 Canada Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.2.3 Mexico Needle-Free Drug Delivery Systems Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.2 UK Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.3 Spain Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.4 Belgium Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.5 France Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.6 Italy Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.7 Denmark Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.8 Finland Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.9 Norway Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.10 Sweden Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.11 Poland Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.12 Russia Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.3.13 Turkey Needle-Free Drug Delivery Systems Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.4.2 Japan Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.4.3 India Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.4.4 South Korea Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.4.5 Pakistan Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.4.6 Bangladesh Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.4.7 Indonesia Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.4.8 Thailand Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.4.9 Singapore Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.4.10 Malaysia Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.4.11 Philippines Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.4.12 Vietnam Needle-Free Drug Delivery Systems Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.5.2 Colombia Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.5.3 Chile Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.5.4 Argentina Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.5.5 Venezuela Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.5.6 Peru Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.5.7 Puerto Rico Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.5.8 Ecuador Needle-Free Drug Delivery Systems Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.6.2 Kuwait Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.6.3 Oman Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.6.4 Qatar Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Needle-Free Drug Delivery Systems Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.7.2 South Africa Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.7.3 Egypt Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.7.4 Algeria Needle-Free Drug Delivery Systems Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Needle-Free Drug Delivery Systems Consumption (2017-2022)

      • 10.8.2 New Zealand Needle-Free Drug Delivery Systems Consumption (2017-2022)

    11 Global Needle-Free Drug Delivery Systems Competitive Analysis

    • 11.1 Antares Pharma

      • 11.1.1 Antares Pharma Company Details

      • 11.1.2 Antares Pharma Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Antares Pharma Needle-Free Drug Delivery Systems Main Business and Markets Served

      • 11.1.4 Antares Pharma Needle-Free Drug Delivery Systems Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Crossject

      • 11.2.1 Crossject Company Details

      • 11.2.2 Crossject Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Crossject Needle-Free Drug Delivery Systems Main Business and Markets Served

      • 11.2.4 Crossject Needle-Free Drug Delivery Systems Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 MedImmune

      • 11.3.1 MedImmune Company Details

      • 11.3.2 MedImmune Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 MedImmune Needle-Free Drug Delivery Systems Main Business and Markets Served

      • 11.3.4 MedImmune Needle-Free Drug Delivery Systems Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Injex Pharma

      • 11.4.1 Injex Pharma Company Details

      • 11.4.2 Injex Pharma Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Injex Pharma Needle-Free Drug Delivery Systems Main Business and Markets Served

      • 11.4.4 Injex Pharma Needle-Free Drug Delivery Systems Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Optinose

      • 11.5.1 Optinose Company Details

      • 11.5.2 Optinose Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Optinose Needle-Free Drug Delivery Systems Main Business and Markets Served

      • 11.5.4 Optinose Needle-Free Drug Delivery Systems Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Pharmajet

      • 11.6.1 Pharmajet Company Details

      • 11.6.2 Pharmajet Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Pharmajet Needle-Free Drug Delivery Systems Main Business and Markets Served

      • 11.6.4 Pharmajet Needle-Free Drug Delivery Systems Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Zogenix

      • 11.7.1 Zogenix Company Details

      • 11.7.2 Zogenix Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Zogenix Needle-Free Drug Delivery Systems Main Business and Markets Served

      • 11.7.4 Zogenix Needle-Free Drug Delivery Systems Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Valeritas

      • 11.8.1 Valeritas Company Details

      • 11.8.2 Valeritas Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Valeritas Needle-Free Drug Delivery Systems Main Business and Markets Served

      • 11.8.4 Valeritas Needle-Free Drug Delivery Systems Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 3M Pharmaceuticals

      • 11.9.1 3M Pharmaceuticals Company Details

      • 11.9.2 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 3M Pharmaceuticals Needle-Free Drug Delivery Systems Main Business and Markets Served

      • 11.9.4 3M Pharmaceuticals Needle-Free Drug Delivery Systems Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Becton Dickinson (BD)

      • 11.10.1 Becton Dickinson (BD) Company Details

      • 11.10.2 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Main Business and Markets Served

      • 11.10.4 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Mystic Pharmaceuticals

      • 11.11.1 Mystic Pharmaceuticals Company Details

      • 11.11.2 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Main Business and Markets Served

      • 11.11.4 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    12 Global Needle-Free Drug Delivery Systems Market Outlook by Types and Applications to 2028

    • 12.1 Global Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Jet-based Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Spring-based Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Laser-based Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Needle-Free Drug Delivery Systems Market Analysis and Outlook to 2028

    • 13.1 Global Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.2.2 Canada Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.2 UK Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.3 Spain Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.5 France Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.6 Italy Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.8 Finland Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.9 Norway Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.11 Poland Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.12 Russia Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.4.2 Japan Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.4.3 India Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.5.3 Chile Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.5.6 Peru Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.6.3 Oman Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Needle-Free Drug Delivery Systems Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Needle-Free Drug Delivery Systems

    • Figure of Needle-Free Drug Delivery Systems Picture

    • Table Global Needle-Free Drug Delivery Systems Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Needle-Free Drug Delivery Systems Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Jet-based Consumption and Growth Rate (2017-2022)

    • Figure Global Spring-based Consumption and Growth Rate (2017-2022)

    • Figure Global Laser-based Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Needle-Free Drug Delivery Systems Consumption by Country (2017-2022)

    • Table North America Needle-Free Drug Delivery Systems Consumption by Country (2017-2022)

    • Figure United States Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Canada Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Mexico Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Table Europe Needle-Free Drug Delivery Systems Consumption by Country (2017-2022)

    • Figure Germany Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure UK Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Spain Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Belgium Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure France Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Italy Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Denmark Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Finland Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Norway Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Sweden Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Poland Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Russia Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Turkey Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Table APAC Needle-Free Drug Delivery Systems Consumption by Country (2017-2022)

    • Figure China Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Japan Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure India Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure South Korea Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Thailand Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Singapore Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Philippines Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Table South America Needle-Free Drug Delivery Systems Consumption by Country (2017-2022)

    • Figure Brazil Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Colombia Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Chile Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Argentina Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Peru Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Table GCC Needle-Free Drug Delivery Systems Consumption by Country (2017-2022)

    • Figure Bahrain Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Oman Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Qatar Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Table Africa Needle-Free Drug Delivery Systems Consumption by Country (2017-2022)

    • Figure Nigeria Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure South Africa Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Egypt Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Algeria Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Table Oceania Needle-Free Drug Delivery Systems Consumption by Country (2017-2022)

    • Figure Australia Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Needle-Free Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Table Antares Pharma Company Details

    • Table Antares Pharma Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Antares Pharma Needle-Free Drug Delivery Systems Main Business and Markets Served

    • Table Antares Pharma Needle-Free Drug Delivery Systems Product Portfolio

    • Table Crossject Company Details

    • Table Crossject Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Crossject Needle-Free Drug Delivery Systems Main Business and Markets Served

    • Table Crossject Needle-Free Drug Delivery Systems Product Portfolio

    • Table MedImmune Company Details

    • Table MedImmune Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune Needle-Free Drug Delivery Systems Main Business and Markets Served

    • Table MedImmune Needle-Free Drug Delivery Systems Product Portfolio

    • Table Injex Pharma Company Details

    • Table Injex Pharma Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Injex Pharma Needle-Free Drug Delivery Systems Main Business and Markets Served

    • Table Injex Pharma Needle-Free Drug Delivery Systems Product Portfolio

    • Table Optinose Company Details

    • Table Optinose Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Optinose Needle-Free Drug Delivery Systems Main Business and Markets Served

    • Table Optinose Needle-Free Drug Delivery Systems Product Portfolio

    • Table Pharmajet Company Details

    • Table Pharmajet Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharmajet Needle-Free Drug Delivery Systems Main Business and Markets Served

    • Table Pharmajet Needle-Free Drug Delivery Systems Product Portfolio

    • Table Zogenix Company Details

    • Table Zogenix Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zogenix Needle-Free Drug Delivery Systems Main Business and Markets Served

    • Table Zogenix Needle-Free Drug Delivery Systems Product Portfolio

    • Table Valeritas Company Details

    • Table Valeritas Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeritas Needle-Free Drug Delivery Systems Main Business and Markets Served

    • Table Valeritas Needle-Free Drug Delivery Systems Product Portfolio

    • Table 3M Pharmaceuticals Company Details

    • Table 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3M Pharmaceuticals Needle-Free Drug Delivery Systems Main Business and Markets Served

    • Table 3M Pharmaceuticals Needle-Free Drug Delivery Systems Product Portfolio

    • Table Becton Dickinson (BD) Company Details

    • Table Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson (BD) Needle-Free Drug Delivery Systems Main Business and Markets Served

    • Table Becton Dickinson (BD) Needle-Free Drug Delivery Systems Product Portfolio

    • Table Mystic Pharmaceuticals Company Details

    • Table Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Main Business and Markets Served

    • Table Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Product Portfolio

    • Figure Global Jet-based Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Spring-based Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Laser-based Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Needle-Free Drug Delivery Systems Consumption Forecast by Country (2022-2028)

    • Table North America Needle-Free Drug Delivery Systems Consumption Forecast by Country (2022-2028)

    • Figure United States Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Needle-Free Drug Delivery Systems Consumption Forecast by Country (2022-2028)

    • Figure Germany Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Needle-Free Drug Delivery Systems Consumption Forecast by Country (2022-2028)

    • Figure China Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Needle-Free Drug Delivery Systems Consumption Forecast by Country (2022-2028)

    • Figure Brazil Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Needle-Free Drug Delivery Systems Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Needle-Free Drug Delivery Systems Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Needle-Free Drug Delivery Systems Consumption Forecast by Country (2022-2028)

    • Figure Australia Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Needle-Free Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.